Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

Vista senzilla d'ítem
dc.contributor.authorDarbà, Josep
dc.contributor.authorKaskens, Lisette
dc.contributor.authorSorio Vilela, Francesc
dc.contributor.authorLothgren, Mickael
dc.date.accessioned2016-04-05T09:54:19Z
dc.date.available2016-04-05T09:54:19Z
dc.date.issued2015-02
dc.date.updated2016-04-05T09:54:25Z
dc.description.abstractThe objective of this study was to estimate the cost-effectiveness of denosumab for fracture prevention compared with no treatment, generic bisphosphonates, and strontium ranelate in a cohort of osteoporotic postmenopausal women in Spain.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec649914
dc.identifier.issn1178-6981
dc.identifier.pmid25709480
dc.identifier.urihttps://hdl.handle.net/2445/96961
dc.language.isoeng
dc.publisherDove Medical Press
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.2147/CEOR.S78349
dc.relation.ispartofClinicoeconomics and Outcomes Research, 2015, vol. 2015, num. 7, p. 105-117
dc.relation.urihttp://dx.doi.org/10.2147/CEOR.S78349
dc.rightscc-by-nc (c) Darbà, Josep et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es
dc.sourceArticles publicats en revistes (Economia)
dc.subject.classificationAnàlisi cost-benefici
dc.subject.classificationMenopausa
dc.subject.classificationOsteoporosi
dc.subject.otherCost effectiveness
dc.subject.otherMenopause
dc.subject.otherOsteoporosis
dc.titleCost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
649914.pdf
Mida:
755.29 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Economia)